Insider · CIK 0001705978

Downs Christopher

Reports to the SEC for 4 companies · LAS VEGAS, NV

sec.gov

Transactions

Companies

Filings

CIK

0001705978

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	VDTAVertical Data Inc.A Award	Interim CFO and Secretary	AAward	+891 sh	$5.61	+$4,995.392	2,248
2026-09-30	VDTAVertical Data Inc.A Award	Interim CFO and Secretary	AAward	+1,357 sh	$3.68	+$4,996.474	1,357
2025-11-17	CNSPCNS Pharmaceuticals, Inc. · Option to purchase common stockA Award	Chief Financial Officer	AAward	+4,881 sh	—	—	4,881
2024-04-08	CNSPCNS Pharmaceuticals, Inc. · Option to purchase common stockA Award	Chief Financial Officer	AAward	+40K sh	—	—	201.572
2024-04-08	CNSPCNS Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+40K sh	—	—	241.572
2024-02-01	CNSPCNS Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+66.7K sh	$0.30	+$20K	103,438
2024-02-01	CNSPCNS Pharmaceuticals, Inc. · Series A Warrant to purchase common stockA Award	Chief Financial Officer	AAward	+66.7K sh	—	—	94,906
2024-02-01	CNSPCNS Pharmaceuticals, Inc. · Series B Warrant to purchase common stockA Award	Chief Financial Officer	AAward	+66.7K sh	—	—	161,572
2023-08-22	CNSPCNS Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+27K sh	$1.27	+$34.2K	36,772
2023-04-28	CNSPCNS Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−521 sh	—	—	28,248
2023-04-28	CNSPCNS Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+521 sh	—	—	9,772
2023-04-17	CNSPCNS Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+3,100 sh	$3.20	+$9,920	9,251
2023-03-29	CNSPCNS Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+6,067 sh	—	—	28,768
2023-02-09	EBET, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,300 sh	—	—	6,300
2023-02-09	EBET, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−6,300 sh	—	—	75,000
2022-04-28	CNSPCNS Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+250K sh	—	—	681,000
2022-03-11	CNSPCNS Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+33K sh	$0.31	+$10.2K	184,500
2022-02-09	EBET, Inc.Restricted Stock UnitsA Award	Director	AAward	+6,300 sh	—	—	81,300
2021-12-06	CNSPCNS Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$0.94	+$4,701.5	151,500
2021-11-19	CNSPCNS Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+4,500 sh	$1.15	+$5,191.65	146,500
2021-02-05	CNSPCNS Pharmaceuticals, Inc. · Option to purchase common stock (right to buy)A Award	Chief Financial Officer	AAward	+131K sh	—	—	431,000
2020-08-24	CNSPCNS Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+142K sh	$2.04	+$290K	142,000
2019-11-13	CNSPCNS Pharmaceuticals, Inc. · Option to purchase common stock (right to buy)A Award	Chief Financial Officer	AAward	+300K sh	—	—	300,000
2017-09-07	INFUInfuSystem Holdings, Inc · Stock Option (right to buy)A Award	Executive Vice President	AAward	+25K sh	—	—	25,000
2017-08-14	INFUInfuSystem Holdings, IncP Purchase	Executive Vice President	PPurchase	+7,900 sh	$1.90	+$15K	28,840
2017-03-16	INFUInfuSystem Holdings, Inc · Stock Option (right to buy)A Award	Executive Vice President	AAward	+20K sh	—	—	20,000
2016-08-18	INFUInfuSystem Holdings, Inc · Stock Option (right to buy)A Award	Executive Vice President	AAward	+60K sh	—	—	60,000

Recent filings

Accepted (ET)
Oct 24
Downs Christopher S0001705978-26-000004
SEC(opens sec.gov)
Nov 194
Downs Christopher0001683168-25-008562
SEC(opens sec.gov)
Apr 104
Downs Christopher0001683168-24-002286
SEC(opens sec.gov)
Feb 64
Downs Christopher0001683168-24-000706
SEC(opens sec.gov)
Aug 234
Downs Christopher0001683168-23-006001
SEC(opens sec.gov)
May 14
Downs Christopher0001683168-23-002829
SEC(opens sec.gov)
Apr 184
Downs Christopher0001683168-23-002495
SEC(opens sec.gov)
Mar 314
Downs Christopher0001683168-23-002095
SEC(opens sec.gov)
Feb 104
Downs Christopher0001683168-23-000760
SEC(opens sec.gov)
Apr 294
Downs Christopher0001683168-22-003054
SEC(opens sec.gov)
Mar 144
Downs Christopher0001683168-22-001631
SEC(opens sec.gov)
Feb 114
Downs Christopher0001683168-22-000872
SEC(opens sec.gov)
Dec 74
Downs Christopher0001683168-21-006141
SEC(opens sec.gov)
Nov 224
Downs Christopher0001683168-21-005869
SEC(opens sec.gov)

Companies

Address

1980 FESTIVAL PLAZA DRIVE, SUITE 300

LAS VEGAS, NV, 89135